Gsa Capital Partners LLP Beyond Spring Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$1.68 - $5.01 $30,933 - $92,249	-18,413 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$4.02 - $16.84 $74,020 - $310,074	18,413 New	18,413 $83,000
Q3 2021 Nov 12, 2021	SELL	$9.26 - $31.31 $103,471 - $349,857	-11,174 Closed	0 $0
Q2 2021 Aug 05, 2021	SELL	$9.37 - $12.12 $84,301 - $109,043	-8,997 Reduced 44.6%	11,174 $117,000
Q1 2021 May 10, 2021	BUY	$10.61 - $15.77 $214,014 - $318,096	20,171 New	20,171 $223,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $72M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.